2013 ATC Meeting

American Transplant Congress, Washington State Convention & Trade Center, May 18-22, 2013, Seattle, WA

secondary banner

Abstract Information

Abstracts will be available to view in late April.  

"Abstract Submission" is now Closed.

Abstract Embargo

In compliance with the Securities and Exchange Commission's Regulation FD (Fair Disclosure), the accepted abstracts are made available to the public on the ATC website and are published in a special supplement of American Journal of Transplantation (AJT) in advance of the meeting. Thus, the first release of the abstracts is a public release. Coverage of additional research being presented at the annual meeting is under embargo until the date of presentation.

Academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an abstract. However, the ATC continues to require that information that goes beyond that contained within the abstract, e.g., discussion of the abstract done as part of a scientific presentation, is to be embargoed until the start of the scientific sessions. Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Journalists failing to abide by the embargo may have their press credentials revoked.


Target Audience
The American Transplant Congress is designed for physicians, surgeons, scientists, nurses, organ procurement personnel and pharmacists who are interested in the clinical and research aspects of solid organ and tissue transplantation. The meeting will provide the most current information in the field of transplant science.

A variety of formats are planned that will encourage the exchange of new scientific and clinical information and support an interchange of opinions regarding care and management as well as socioeconomic, ethical and regulatory issues relevant to organ and tissue transplantation.

Scientific material will be presented through symposia, concurrent workshops, peer reviewed oral and poster presentations as well as small parallel workshops designed for in-depth exploration of both clinical and basic science topics.

The purpose is the meeting is to:

  • Review and evaluate the latest clinical and basic science advances in transplantation science, medicine and surgery;

  • Investigate recent developments in transplant biology, immunology and organ preservation;

  • Examine the broad but critical issues in transplantation, including social and policy issues.

Submitting an abstract to the American Transplant Congress means that it will be peer reviewed and may be accepted for either an oral or a poster presentation. All accepted abstracts will be published in a Supplement to The American Journal of Transplantation, the Joint Journal of the American Society of Transplant Surgeons (ASTS) and American Society of Transplantation (AST). You may submit as many abstracts as you wish. 


By March 1, 2013, all submitters will receive notification of their submitted abstracts status for the meeting. If you do NOT receive an email notification regarding your abstract by March 9th, please send an email inquiry to Technical Support at c4asupport@coetruman.com or call1.507.403.2305.

Your email will receive a prompt answer. Inquiries before March 1, 2013 will not receive a response. All presenters are expected to cover their own travel and lodging and pay the registration fees.


  1. Abstract Preparation: Abstracts must conform exactly to the instructions provided for electronic submission (by the American Transplant Congress). Abstracts must be submitted in English and all presentations will be in English.

  2. Publication: Abstracts accepted for oral or poster presentation will be published in a supplement to the American Journal of Transplantation, the Joint Journal of the American Society of Transplant Surgeons and the American Society of Transplantation. Abstracts not accepted for presentation will not be published. Abstracts and program will also be posted prior to the meeting on the American Transplant Congress website. Please check this for official publication date.

  3. Previous Presentation of Abstracts: Abstracts will not be considered for presentation if they will be published as an article within 30 days prior to the start of ATC, or if they have been previously presented at a national meeting not sponsored by the ASTS or AST. Exception: Abstracts presented or accepted for presentation by a young investigator (defined as a student, resident, or fellow), including those published in a journal supplement associated with an AST or ASTS national meeting within the previous year, can be submitted to the ATC.

  4. Informed Consent: Any studies involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association (Clinical Research 1966:14:103) and must meet all of the requirements governing informed consent of the country in which the study was performed. Any transplant procedures performed must meet with the prevailing ethical standards.

  5. Use of Animals: All studies involving the use of animals must conform to the 1991 revision of "Guiding Principles in the Care and Use of Animals" (American Physiological Association).

  6. Employees of Commercial Interests: ATC recognizes that employees of commercial interests are often involved in research and discovery and encourages these employees to submit abstracts to facilitate the flow of new information. In order to be compliant with the various continuing medical education regulatory bodies, abstracts submitted by employees of commercial interests should not include patient care recommendations. They should focus on the biology, physiology or physics and include content about the discovery process. Abstracts should avoid discussion of products, treatment or diagnostics. Abstracts from employees of commercial interests that are selected for oral or poster presentation will be subject to additional review prior to ATC.

  7. Co-Author Approval: Ensure that all co-authors approve of the abstract submission, publication, and potential presentation. Abstracts cannot be changed or withdrawn after January 17, 2013.

  8. Abstract Review: Abstracts will be blinded for peer review. Authors should be cautious in using institutional references in the body of the abstract. Do not put author names and/or affiliations in the body. Abstracts which include reference to authors or institutions will not be reviewed.

  9. Awards: American Transplant Congress will grant a number of travel awards to assist young investigators to attend the joint meeting. The award is designed to help off set the expense to attend the meeting. Therefore, you must attend the meeting in order to receive the award. If you are selected for an award but do not attend the meeting, you will forfeit the monies of the award. To be eligible for an award, an individual must be a trainee and as such must be within two (2) years completion of their training and/or fellowship, in a program in which either an ASTS or AST member is associated. Awardees will be selected from the pool of eligible applicants based upon the abstract's degree of excellence as determined by the Joint Planning Committee. To apply for these awards, check the appropriate checkboxes and complete the award forms in the submission program. A supporting letter must be uploaded on the Questionnaire page of the Submission Program. This letter must be signed by the applicant's Training Program Director verifying that the award applicant is indeed a young investigator. Authors will not be considered for a travel award if the required letter is not uploaded. The award applicant MUST be the presenting author. No exceptions will be made.

  10. Changes to Abstract: Any changes prior to the submission deadline of December 3, 2012, 11:59 PM, Central Time, must be made as a resubmission. After the deadline, minor changes to your submitted abstract should be sent to Changes@coetruman.com. These requests must be sent prior to the January 17, 2013 deadline. Any corrections, withdrawals and/or changes will not be accepted after this date.

  11. Abstract Receipt Confirmation: You will receive an email confirmation within two business days of submitting your abstract. If you submit on the deadline date and do not receive a confirmation within two business days, please contact Coe-Truman Technical Support at: c4asupport@coetruman.com or 1.507.403.2305.

  12. Abstract Submission Fee: A submission fee of $25 for ASTS and/or AST members (first OR last author) or $50 for non-members is required to submit each abstract. This fee is required at the time of submission and is accepted by online credit card payment only.

  13. Author Disclosure: ALL abstract authors are required to disclose any conflict of interest.